Endocrinology and Metabolism (original) (raw)

Table 1 Baseline Characteristics of the Study Population (n=8,898)

Values are expressed as mean±SD or number (%).

BMI, body mass index; HbA1c, glycated hemoglobin; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; HOMA-IR, homeostasis model of assessment-insulin resistance.

aHOMA-IR=[fasting plasma glucose (mmol/L)×fasting plasma insulin]/22.5.

Table 2 Metabolic Syndrome and the Risk of Cardiovascular Disease during Follow-Up (n=8,898)

Values are expressed as number (%). Adjusted for age, smoking status, low density lipoprotein cholesterol, and homeostasis model of assessment-insulin resistance.

MetS, metabolic syndrome; HR, hazard ratio; CI, confidence interval; CVD, cardiovascular disease; CHD, coronary heart disease.

aCVD was defined as occurrence of CHD and/or stroke.

Table 3 Individual Metabolic Syndrome Components and the Risk of Cardiovascular Disease during Follow-Up (n=8,898)

Values are expressed as hazard ratio (95% confidence interval). Adjusted for age, smoking status, low density lipoprotein cholesterol, homeostasis model of assessment-insulin resistance, and metabolic syndrome components.

CVD, cardiovascular disease; CHD, coronary heart disease; TG, triglycerides; HDL, high density lipoprotein cholesterol.

aP<0.05; bP<0.001.

Table 4 Risk of Cardiovascular Disease according to Number of Metabolic Syndrome Components during Follow-Up (n=8,898)

Adjusted for age, smoking status, low density lipoprotein cholesterol, and homeostasis model of assessment-insulin resistance.

HR, hazard ratio; CI, confidence interval.